Abstract |
These studies were undertaken to determine the mechanism for augmented tumoricidal activity of alveolar macrophages (AM) in mice injected intravenously with multilamellar liposomes containing a lipopeptide analogue of Gram-negative bacteria cell wall (MLV-CGP 31362) and intraperitoneally with interleukin 2 (IL-2). BALB/c mice were injected into the kidney with syngeneic renal carcinoma cells. Ten days later, this kidney was resected, and the mice were treated intravenously with MLV- CGP 31362 and/or intraperitoneally with IL-2. Treatment with MLV- CGP 31362 led to a reduction in the number of lung metastases, whereas treatment with IL-2 alone did not. The coadministration of intravenous liposomes and intraperitoneal IL-2 produced significant eradication of lung metastases. MLV- CGP 31362 (iv) and IL-2 (ip) were injected both into control immune-competent and nude mice or into mice whose natural killer (NK) cells had been depleted by systemic administration of anti- asialo GM1 antibodies. MLV- CGP 31362 activated tumoricidal properties in AM of all groups of mice. The additive tumoricidal activation of AM by IL-2 was associated with its effects on both T cells and NK cells.
|
Authors | T Utsugi, C P Dinney, J J Killion, D Brown, I J Fidler |
Journal | Lymphokine and cytokine research
(Lymphokine Cytokine Res)
Vol. 10
Issue 6
Pg. 487-93
(Dec 1991)
ISSN: 1056-5477 [Print] United States |
PMID | 1804312
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Drug Carriers
- Interleukin-2
- Liposomes
- Oligopeptides
- Peptide Fragments
- CGP 31362
|
Topics |
- Animals
- Cell Communication
(drug effects)
- Cytotoxicity, Immunologic
(drug effects)
- Drug Carriers
- Interleukin-2
(administration & dosage)
- Killer Cells, Natural
(drug effects)
- Liposomes
- Macrophage Activation
(drug effects)
- Macrophages, Alveolar
(drug effects)
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Neoplasm Metastasis
- Oligopeptides
(administration & dosage)
- Peptide Fragments
(administration & dosage)
- T-Lymphocytes
(drug effects)
- Tumor Cells, Cultured
|